Epidemiological characteristics and risk factors for severity of product-related injuries in children during

Jie Chen1, Yanqi Lan1, Zhuoping Zhang2

  • 1Xiamen Center for Disease Control and Prevention, Xiamen, Fujian, China.

PubMed

Insights

The COVID-19 pandemic

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic created a natural experiment to study the impact of non-pharmaceutical interventions (NPIs) on childhood injuries.
  • Understanding how NPIs affect injury patterns and severity is crucial for public health strategies during emergencies.

Purpose of the Study:

  • To assess the impact of NPIs on the epidemiological characteristics of product-related injuries in children.
  • To determine the factors influencing the severity of these injuries during different pandemic phases.

Main Methods:

  • Analysis of 39,245 product-related injury cases in children (1-17 years) from 2016-2024 using the Xiamen Injury Surveillance System.
  • Categorization of the study period into pre-pandemic, during NPIs, and post-NPIs phases.
  • Multivariable logistic regression models with interaction terms to analyze injury severity and effect modification by NPIs.

Main Results:

  • During NPIs, home injuries increased to 56.38%, with rises in foreign body injuries and burns/scalds.
  • NPIs significantly increased severe injury risk for products like agro-forestry-fishery items, household appliances, and toys.
  • Conversely, injury severity at schools/public places decreased in the post-NPIs period compared to pre-pandemic.

Conclusions:

  • Non-pharmaceutical interventions altered childhood injury risks, particularly increasing the severity of injuries from home-related products.
  • Targeted product safety interventions within homes are essential during public health emergencies.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...